165 related articles for article (PubMed ID: 35587295)
1. Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Ursino S; Calistri E; De Felice F; Bonomo P; Desideri I; Franco P; Arcadipane F; Colosimo C; Mazzola R; Maddalo M; Gonnelli A; Malfatti G; Morganti R; Musio D; Paiar F
Dysphagia; 2023 Feb; 38(1):159-170. PubMed ID: 35587295
[TBL] [Abstract][Full Text] [Related]
2. Patient-reported outcomes following parotid-sparing intensity-modulated radiotherapy for head and neck cancer. How important is dysphagia?
Roe JW; Drinnan MJ; Carding PN; Harrington KJ; Nutting CM
Oral Oncol; 2014 Dec; 50(12):1182-7. PubMed ID: 25448227
[TBL] [Abstract][Full Text] [Related]
3. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma.
Goepfert RP; Lewin JS; Barrow MP; Fuller CD; Lai SY; Song J; Hobbs BP; Gunn GB; Beadle BM; Rosenthal DI; Garden AS; Kies MS; Papadimitrakopoulou VA; Schwartz DL; Hutcheson KA
Laryngoscope; 2017 Apr; 127(4):842-848. PubMed ID: 27440393
[TBL] [Abstract][Full Text] [Related]
4. Comparative Study of Dysphagia-optimized Intensity Modulated Radiotherapy (Do-IMRT) and Standard Intensity Modulated Radiotherapy (S-IMRT) and Its Clinical Correlation in Head and Neck Cancer Patients.
Batham S; Gupta S; Ghosh A; Gupta IJ; Johny D; Srivastava S; Singh N; Bhatt M; Gupta R; Bhosale VV; Negi M
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3697-3704. PubMed ID: 38019227
[TBL] [Abstract][Full Text] [Related]
5. DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer.
Petkar I; Rooney K; Roe JW; Patterson JM; Bernstein D; Tyler JM; Emson MA; Morden JP; Mertens K; Miles E; Beasley M; Roques T; Bhide SA; Newbold KL; Harrington KJ; Hall E; Nutting CM
BMC Cancer; 2016 Oct; 16(1):770. PubMed ID: 27716125
[TBL] [Abstract][Full Text] [Related]
6. Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy.
Goepfert RP; Lewin JS; Barrow MP; Gunn GB; Fuller CD; Beadle BM; Garden AS; Rosenthal DI; Kies MS; Papadimitrakopoulou V; Lai SY; Gross ND; Schwartz DL; Hutcheson KA
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):700-708. PubMed ID: 27485284
[TBL] [Abstract][Full Text] [Related]
7. Prospective evaluation of patient reported swallow function with the Functional Assessment of Cancer Therapy (FACT), MD Anderson Dysphagia Inventory (MDADI) and the Sydney Swallow Questionnaire (SSQ) in head and neck cancer patients.
Peng LC; Hui X; Cheng Z; Bowers MR; Moore J; Cecil E; Choflet A; Thompson A; Muse M; Kiess AP; Page BR; Gourin CG; Fakhry C; Szczesniak M; Maclean J; Wu P; Cook I; McNutt TR; Quon H
Oral Oncol; 2018 Sep; 84():25-30. PubMed ID: 30115472
[TBL] [Abstract][Full Text] [Related]
8. Association Between Objective Ratings of Swallowing and Dysphagia-Specific Quality of Life in Patients Receiving (Chemo)radiotherapy for Oropharyngeal Cancer.
Wishart LR; Harris GB; Cassim N; Alimin S; Liao T; Brown B; Ward EC; Nund RL
Dysphagia; 2022 Aug; 37(4):1014-1021. PubMed ID: 34625841
[TBL] [Abstract][Full Text] [Related]
9. Quality of life and swallowing with standard chemoradiotherapy versus accelerated radiotherapy and panitumumab in locoregionally advanced carcinoma of the head and neck: A phase III randomised trial from the Canadian Cancer Trials Group (HN.6).
Ringash J; Waldron JN; Siu LL; Martino R; Winquist E; Wright JR; Nabid A; Hay JH; Hammond A; Sultanem K; Hotte S; Leong C; El-Gayed AA; Naz F; Ramchandar K; Owen TE; Montenegro A; O'Sullivan B; Chen BE; Parulekar WR
Eur J Cancer; 2017 Feb; 72():192-199. PubMed ID: 28040660
[TBL] [Abstract][Full Text] [Related]
10. Swallowing sparing intensity modulated radiotherapy versus standard parotid sparing intensity-modulated radiotherapy for treatment of head and neck cancer: a randomized clinical trial.
Ashour MG; Shouman TH; Hassouna AH; Mokhtar MH; Emad El Din R; Youssef AA; Gomaa MM; Abdelgeleel S
Acta Oncol; 2022 Feb; 61(2):134-140. PubMed ID: 35000532
[TBL] [Abstract][Full Text] [Related]
11. What is a clinically relevant difference in MDADI scores between groups of head and neck cancer patients?
Hutcheson KA; Barrow MP; Lisec A; Barringer DA; Gries K; Lewin JS
Laryngoscope; 2016 May; 126(5):1108-13. PubMed ID: 26542529
[TBL] [Abstract][Full Text] [Related]
12. Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial.
Nutting C; Finneran L; Roe J; Sydenham MA; Beasley M; Bhide S; Boon C; Cook A; De Winton E; Emson M; Foran B; Frogley R; Petkar I; Pettit L; Rooney K; Roques T; Srinivasan D; Tyler J; Hall E;
Lancet Oncol; 2023 Aug; 24(8):868-880. PubMed ID: 37423227
[TBL] [Abstract][Full Text] [Related]
13. Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing.
; Grant S; Kamal M; Mohamed ASR; Zaveri J; Barrow MP; Gunn GB; Lai SY; Lewin JS; Rosenthal DI; Wang XS; Fuller CD; Hutcheson KA
Cancer; 2019 May; 125(10):1654-1664. PubMed ID: 30633325
[TBL] [Abstract][Full Text] [Related]
14. Swallowing-sparing intensity-modulated radiotherapy for head and neck cancer patients: treatment planning optimization and clinical introduction.
van der Laan HP; Gawryszuk A; Christianen ME; Steenbakkers RJ; Korevaar EW; Chouvalova O; Wopken K; Bijl HP; Langendijk JA
Radiother Oncol; 2013 Jun; 107(3):282-7. PubMed ID: 23742959
[TBL] [Abstract][Full Text] [Related]
15. Head and Neck Cancer: A Study on the Complex Relationship between QoL and Swallowing Function.
Strüder D; Ebert J; Kalle F; Schraven SP; Eichhorst L; Mlynski R; Großmann W
Curr Oncol; 2023 Dec; 30(12):10336-10350. PubMed ID: 38132387
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Eapen L; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
Lancet Oncol; 2019 Oct; 20(10):1349-1359. PubMed ID: 31416685
[TBL] [Abstract][Full Text] [Related]
17. Pattern of dysphagia after swallowing-sparing intensity-modulated radiotherapy (IMRT) of head and neck cancers: results of a mono-institutional prospective study.
Ursino S; Cocuzza P; Seccia V; Delishaj D; Cristaudo A; Pasqualetti F; Giusti P; Santopadre S; Morganti R; Fiorica F; Paiar F; Fattori B
Strahlenther Onkol; 2018 Dec; 194(12):1114-1123. PubMed ID: 29987341
[TBL] [Abstract][Full Text] [Related]
18. Validity and reliability of the MD Anderson dysphagia inventory in English and Chinese in head and neck cancer patients.
Yee K; Wong SM; Teo I; Loy J; Roche E; Tan YP; Tan HK; Tan NC; Iyer NG
Asia Pac J Clin Oncol; 2020 Dec; 16(6):372-379. PubMed ID: 32573112
[TBL] [Abstract][Full Text] [Related]
19. Validation and application of the M.D. Anderson Dysphagia Inventory in patients treated for head and neck cancer in Brazil.
Guedes RL; Angelis EC; Chen AY; Kowalski LP; Vartanian JG
Dysphagia; 2013 Mar; 28(1):24-32. PubMed ID: 22684923
[TBL] [Abstract][Full Text] [Related]
20. Minimum Clinically Important Differences of the Hospital for Special Surgery Dysphagia and Dysphonia Inventory and Other Dysphagia Measurements in Patients Undergoing ACDF.
Okano I; Ortiz Miller C; Salzmann SN; Hoshino Y; Shue J; Sama AA; Cammisa FP; Girardi FP; Hughes AP
Clin Orthop Relat Res; 2020 Oct; 478(10):2309-2320. PubMed ID: 32282534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
